Body mass index has dominated health screening for decades despite a well-documented list of limitations. It cannot distinguish fat from muscle, it ignores where fat is stored, and it was built on population data from primarily white European men. For most individuals, especially women, a better first screening metric is available: waist-to-height ratio (WHtR).
The rule is simple: keep your waist circumference less than half your height. Below that threshold, cardiometabolic risk is substantially lower. Above it, risk rises in a dose-response fashion. This guide explains the evidence, shows you how to measure correctly, and puts each risk band in clinical context.
Why fat distribution matters more than total weight
Not all body fat carries equal risk. The critical distinction is between visceral fat and subcutaneous fat.
Visceral fat surrounds organs in the abdominal cavity. It is metabolically active — it secretes inflammatory cytokines, disrupts insulin signaling, raises triglycerides, and contributes to atherosclerotic plaque formation. High visceral fat is independently associated with type 2 diabetes, cardiovascular disease, metabolic syndrome, and overall mortality.
Subcutaneous fat sits beneath the skin. Most of the fat in the hips, thighs, and buttocks is subcutaneous. It is far less metabolically harmful than visceral fat and may even be protective: the “pear shape” pattern of fat storage (peripheral predominance) is associated with lower cardiometabolic risk than the “apple shape” (central predominance), even at the same BMI or body weight.
BMI captures total mass without any regard for where it is distributed. A woman at BMI 28 with most of her fat in her hips and thighs has a very different risk profile from a woman at BMI 28 with predominant abdominal fat accumulation. WHtR captures the abdominal component; BMI does not.
The evidence: Ashwell 2012 meta-analysis
The most influential evidence for WHtR as a cardiometabolic risk predictor comes from a 2012 meta-analysis by Margaret Ashwell and colleagues (Ashwell, Gunn, and Gibson, Obesity Reviews 2012). The analysis included 78 studies involving over 300,000 participants across multiple populations.
Key findings:
- WHtR was a significantly better predictor of cardiovascular disease, type 2 diabetes, hypertension, dyslipidemia, and all-cause mortality than either BMI or waist circumference alone.
- WHtR outperformed BMI consistently across all subgroups analyzed — both sexes, multiple ethnic groups, and different age ranges.
- The superiority of WHtR over BMI was particularly pronounced for diabetes and cardiovascular disease outcomes.
- The 0.5 boundary — waist less than half of height — was validated as a clinically meaningful threshold that works across sexes and ethnic groups without separate cutoffs.
Subsequent meta-analyses have consistently replicated these findings. Savva et al. (2013) found WHtR more predictive of metabolic syndrome than BMI or waist circumference alone across 13 studies. A 2020 meta-analysis of 31 prospective cohort studies (Jayedi and Shab-Bidar, Advances in Nutrition) confirmed WHtR’s predictive superiority for all-cause mortality.
The appeal of WHtR over simpler waist-circumference cutoffs is that it adjusts for height: a 5’2” woman and a 5’10” woman are not well served by the same absolute waist measurement threshold, but the proportional relationship to height provides a fair comparison across body sizes.
How to measure correctly
Accurate measurement is essential — a few centimeters of error at the tape measure changes your ratio meaningfully.
Locating the measurement site
The correct waist measurement site for WHtR is the natural waist: the midpoint between the inferior margin of the last rib and the superior border of the iliac crest (the ridge of the hip bone). In most people, this falls approximately 1–2 cm above the navel, but anatomical variation is significant. Find your lowest rib by pressing into your side; find your hip crest by pressing down from the waist. Measure between those two landmarks.
This is important because alternative measurement conventions — at the navel, or at the narrowest point — give different readings and are less consistent across body shapes.
Measurement technique
- Use a non-stretch fabric tape measure or a dedicated body measurement tape. Metal tape measures do not conform to the body and give less accurate readings.
- Stand upright, feet together, arms slightly away from the body.
- Breathe normally and exhale before measuring. Do not hold your breath in or expand your abdomen.
- The tape should be snug but not compressing tissue — a finger should be able to slide under it.
- Read to the nearest 0.5 cm or 0.25 inch.
- Take two measurements and average them. If the two measurements differ by more than 1 cm, take a third and average the closest two.
Timing
Small variations in waist circumference occur across the day — slightly lower in the morning before eating and drinking, slightly higher in the evening. For consistency and to get a comparable baseline reading on future measurements, measure in the morning before breakfast.
Converting to WHtR
Divide your waist circumference by your height. Both measurements must be in the same units (centimeters or inches — it does not matter which, as long as both are the same).
Example:
- Waist: 72 cm, Height: 163 cm
- WHtR = 72 / 163 = 0.44 (low risk)
Example:
- Waist: 88 cm, Height: 160 cm
- WHtR = 88 / 160 = 0.55 (moderate to high risk)
Risk bands: what each range means
Ashwell and colleagues have proposed a boundary system using four risk zones, simplified from the original five-zone model in Ashwell and Hsieh (2005):
| WHtR range | Classification | Clinical interpretation |
|---|---|---|
| Under 0.40 | Very lean | Low risk; some evidence of higher all-cause mortality at very low values (under 0.35) — underweight considerations |
| 0.40 to 0.49 | Healthy range | Lowest cardiometabolic risk; target range for most adults |
| 0.50 to 0.59 | Increased risk | Elevated risk for cardiovascular disease, metabolic syndrome, type 2 diabetes; lifestyle intervention recommended |
| 0.60 and above | High risk | Substantially elevated cardiometabolic risk; clinical evaluation warranted |
The 0.5 boundary is the single most useful number to remember. Ashwell’s “keep your waist to less than half your height” rule communicates this in a way that does not require a calculator.
Important nuances by population
WHtR performs well across ethnic groups, but absolute risk at any given WHtR may vary. South Asian, East Asian, and Middle Eastern women tend to develop metabolic complications at lower absolute waist circumferences than Western European women — some research suggests a lower WHtR threshold (around 0.46–0.48) may be more appropriate for these populations. The 2004 WHO Expert Consultation on appropriate BMI cutoffs for Asian populations acknowledged the evidence for ethnicity-specific thresholds, and analogous considerations apply to WHtR.
At the other end, older women (65+) may have slightly higher optimal WHtR ranges — some evidence suggests the J-shaped mortality curve shifts slightly rightward with age, similar to the BMI literature.
WHtR vs. other measurements
WHtR vs. BMI
| Feature | BMI | WHtR |
|---|---|---|
| Measures | Total mass relative to height | Abdominal fat relative to height |
| Distinguishes fat from muscle | No | Partially (waist is largely fat-driven) |
| Captures fat distribution | No | Yes |
| Works across sexes without adjustment | No (women have more fat per BMI unit) | Better than BMI |
| Works across ethnic groups | Requires adjusted cutoffs | More consistent |
| Predicts CVD, diabetes, mortality | Moderate | Better than BMI in most meta-analyses |
WHtR vs. waist-to-hip ratio (WHR)
WHR (waist divided by hip circumference) also captures fat distribution and distinguishes “apple” from “pear” body shapes. WHO thresholds for elevated risk are WHR above 0.85 for women and 0.90 for men.
WHtR has several practical advantages over WHR:
- Only one measurement site needed (vs. two for WHR)
- Less sensitive to measurement variability at the hip
- Adjusts for body size (height) in a way that WHR does not
Both are useful; WHtR is more practical for self-monitoring.
You can calculate both with the Body Shape Calculator, which also produces WHR and body shape category alongside WHtR. The BMI Calculator provides BMI with ethnicity-adjusted interpretation for comparison.
WHtR for women specifically
Women’s cardiometabolic risk profile shifts significantly across the lifespan in ways that WHtR captures better than BMI:
- Reproductive years: Estrogen promotes peripheral fat storage (hips, thighs) and protects against visceral fat accumulation. WHtR tends to be lower in premenopausal women relative to their BMI.
- Perimenopause and menopause: Estrogen decline shifts fat distribution from peripheral to central. Many women gain abdominal fat without significant weight change — a phenomenon BMI cannot detect. WHtR captures this redistribution directly.
- PCOS: Insulin resistance in PCOS promotes abdominal fat deposition even in women with lean or normal-range BMI. WHtR is more likely to flag the metabolic risk in lean PCOS patients than BMI, which may read as entirely normal.
- Pregnancy: WHtR is not interpretable during pregnancy. Pre-pregnancy WHtR is the relevant baseline.
The bottom line
WHtR is the most practical improvement over BMI available without a clinic visit. Measure your waist at the midpoint between your lowest rib and hip crest, divide by your height (in the same units), and aim for below 0.5. A ratio under 0.5 consistently corresponds to lower cardiovascular, diabetes, and mortality risk across populations in the literature — regardless of what the scale says.
Use the Body Shape Calculator to compute your WHtR alongside WHR and body shape category. Use the BMI Calculator for the population-screening comparison. Neither number alone tells your complete health story, but WHtR tells it more accurately than BMI does for most women.